| Christine Mcmahan, NP | |
|
2000 E Greenville St, Cancer Center 3rd Floor, Anderson, SC 29621-1580 | |
| (864) 225-5131 | |
| (864) 225-2592 |
| Full Name | Christine Mcmahan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 28 Years |
| Location | 2000 E Greenville St, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609813542 | NPI | - | NPPES |
| NP1045 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | ANP1209 (South Carolina) | Secondary |
| 363LW0102X | Nurse Practitioner - Women's Health | 1209 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.
Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.
More than 30 European universities and companies, led by GlaxoSmithKline, are joining forces in a six-year programme funded by the Innovative Medicines Initiative (IMI) for the sum of EUR 85 millions with the aim of developing new antibiotics against Gram-negative pathogens.
The University of Liverpool has formed a new spin-out company, PhenUtest Diagnostics Ltd, to take forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.
Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.
More than 30 European universities and companies, led by GlaxoSmithKline, are joining forces in a six-year programme funded by the Innovative Medicines Initiative (IMI) for the sum of EUR 85 millions with the aim of developing new antibiotics against Gram-negative pathogens.
The University of Liverpool has formed a new spin-out company, PhenUtest Diagnostics Ltd, to take forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.
Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.
More than 30 European universities and companies, led by GlaxoSmithKline, are joining forces in a six-year programme funded by the Innovative Medicines Initiative (IMI) for the sum of EUR 85 millions with the aim of developing new antibiotics against Gram-negative pathogens.
The University of Liverpool has formed a new spin-out company, PhenUtest Diagnostics Ltd, to take forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Mcmahan, NP Po Box 100174, Columbia, SC 29202-3174 Ph: (864) 225-5131 | Christine Mcmahan, NP 2000 E Greenville St, Cancer Center 3rd Floor, Anderson, SC 29621-1580 Ph: (864) 225-5131 |
News Archive
Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.
Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.
More than 30 European universities and companies, led by GlaxoSmithKline, are joining forces in a six-year programme funded by the Innovative Medicines Initiative (IMI) for the sum of EUR 85 millions with the aim of developing new antibiotics against Gram-negative pathogens.
The University of Liverpool has formed a new spin-out company, PhenUtest Diagnostics Ltd, to take forward state-of-the-art medical device technology that aims to revolutionise the diagnosis of Urinary Tract Infections (UTIs).
› Verified 9 days ago